2/24 Cancers of Male Repro Tract - Corbett Flashcards

1
Q

male devpt timeline and events

A

gonads and repro tracts are indifferent until wk7

  • SRY- → female path of devpt
  • SRY+ → male path of devpt, gonad → testis (spermatogonia, Sertoli cells, Leydig cells)
    • Leydig cells: testosterone → support growth of mesonephric ducts
    • some testosterone → DHT : supports devpt of external genitalia (prostate gland, penis, scrotum)
    • Sertoli cells: antiMullerian hormone → regression of paramesonephric ducts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cryptorchidism

A

incomplete descent of testis from abd to scrotum

  • uncorrected? assoc w tubular atrophy and sterility
  • 3-5x risk for testicular cancer (arises from foci of intratubular germ cell neoplasia within atrophic tubules)

orchiopexy reduces risk of sterility and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

testicular torsion

A

acute onset of unilateral scrotal pain w assoc n/v

  • abd pain, fever
  • scrotal swelling, pain with palp, loss of cremasteric reflex

dx: scrotal ultrasound

rx: surgical exploration, detorsion, bilat orchidopexy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

testicular tumor risk factors

A
  • familiar risk w germ cell tumors : 8-10x in brothers
  • genetic disorders
    • testicular dysgenesis syndrome
    • Kleinfelter Syndrome
    • cryptorchidism
  • racial factors
    • higher in Caucasians
    • AfAm present with higher grade disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

testicular tumors

clinical pres

A

nodule or painless swelling

  • ache in lower abd or scrotum
  • acute pain
  • metastatic disease
  • gynecomastia )assoc with hCG, germ cell tumors, Leydig cell tumors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

testicular tumors

breakdown

A

95% germ cell tumors

  1. “embryo-like”
    • spermatocytic seminoma
    • teratoma (non-seminoma)
  2. “placenta-like”
    • yolk sac
    • embryonal carcinoma
    • choriocarcinoma

*exception: OLDER MEN - testicular mass - most likely diffuse large B cell lymphoma

  • rapid growing, 30% BCL6 overexp

**exception: INFANTS/YOUNG CHILDREN - testicular tumor - most likely yolk sac tumor (elevated serum AFP)

  • 16-18mo: pure YST
  • 25-35y: YST in mixed GCT (rare in adults)
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

testicular germ cell neoplasia in situ

precursor lesion

A

precursor lesion

  • seen in 90-100% testes adjacent to GCT
  • assoc with gonadal dysgenesis, androgen insensitivity syndrome, infertility, cryptorchidism, contralat tests if prior test tumor

50% → germ cell tumor in 5y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

seminoma

A

most common type of GCT (50%)

peak in 30s, almost never in infants

uniform tumor cells with abundant clear cytoplasm, distinct cell border, large central nuclei w prominent nucleoli

  • PLAP+
  • OCT3/4+
  • CD117+ (ckit overexpression in 25%)
  • cytokeratin -

excellent prognosis bc usually stay confined to testis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

spermatocytic seminoma

A

v rare

older pt (mean 54yr)

doesn’t arise from ITGCN, not assoc with cryptorchidism

no serum tumor markers (AFR, hCG, LDH)

no race predilection in contrast to other GCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

embryonal carcinoma

A

second most common GCT

poorest prognosis of all GCTs

  • more aggressive than seminomas
  • serum alphaAFP and HCG can be elevated
  • features:
    • freq extend through tunica albuiginea
    • poorly demarcated
    • cells grow in alveolar or tubular patterns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

choriocarcinoma

A
  • pure choriocarcinoma: v rare, most aggressive
  • often small nodule, almost always with hematogenous spread to lungs/liver
  • marked elevation in serum hCG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

recall:

testicular/ovarian tumors having syncytiotrophoblasts…

A

produce beta-hCG!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

teratoma

A

tumor with mature or immature somatic tissue from more than one germ layer

peaks: under4y, 20s-40s

  • pediatric: benign
  • postpubertal: all malignant

mature tissue with hair, cartlage, bone/teeth, muscle and nerve, squamous cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

testicular neoplasm

MUST KNOW

A

biopsy is absolutely contraindicated bc

  1. leaves inguinal portion of spermatic cord intact → may alter lymphatic drainage of testis
  2. increases risk of local recurrence
  3. might lead to pelvic or inguinal lymph node metastasis

tx: radical inguinal orchiectomy (removal of tumor bearing testis and spermatic cord to level of internal inguinal ring)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

seminoma vs NSCCT

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sex cord tumors

A

1. Leydig cell tumors

  • most common
  • hormonally active:
    • androgens → precocious puberty
    • estrogens → gynecomastia
    • corticosteroids
  • patho feature: crystalloids of Reinke

2. Sertoli cell tumors

  • mostly benign
  • hormonally silent
17
Q

testicular tumors summary

A
18
Q

prostate gland

A

four distinct zones

  1. peripheral
  2. central
  3. transitional
  4. periurethral

proliferative lesions are different in each region:

  • hyperplasias: TZ
    • more likely to cause obstruction
  • carcinomas: PZ
    • not as likely to cause obstruction

glands are lined by two layers of cells

  • (cell growth in response to androgens)
  1. basal layer of low cuboidal epi
  2. layer of columnar secretory cells

glands separated by fibromuscular stroma

19
Q

BPH

A

benign prostatic hypertrophy

most common benign prostatic disease in men over 50

nodular hyperplasia of prostatic stromal and epithelial cells in periurethral region

  • formation of discrete nodules
  • NOT PREMALIGNANT
  • can cause urethral obstruction

pathogenesis

  • stromal cells: DHT (main prostatic androgen) → binds to nuclear androgen receptor
    • more potent than testosterone
    • higher affinity for AR
  • DHT binding to AR → FGF synthesis → stromal proliferation

*DHT production requires 5alpha reductase activity (test → DHT)

  • DHT inhibitors can reduce prostate size, lower PSA levels
20
Q

BPH

clinical manifestations

management/tx

A
  • frequency, urgency, hesitancy, straining to void, poor stream/dribbling, feeling like bladder not empty, nocturia
  • abd/suprapubic distension

tx/mgmt

  • fluid management, avoid alcohol/caffeine
  • pharm:
    • alpha1 blockers
    • 5alpha reductase inhibitors
  • TURP: transurethral resection of prostate
21
Q

adenocarcinoma of prostate

A

most common form of cancer in men

  • risks: family history, age, race (AfAm), BRCA2

pathogenesis: most early prostate cancers are androgen- and androgen_receptor-dependent

  • AR polymorphisms and mutations can play a role in racial predisp
  • 70% in peripheral zone
  • microscopy shows pleomorphic cells, single layer glands, no secretions
  • malignant gland lacks basal cells
22
Q

prostate cancer

presetation (dx)

metastasis

A

presents as

  • nodule on digital rectal exam
  • rising PSA

*since most arise away from the urethra, urinary sx detected late

metastatic disease

  1. lymph nodes: obdurator → para-aortic nodes
    • (prostate and testicle go paraaortic; penis goes groin)
  2. hematogenous: bones, esp axial skeleton
    • osteoBLASTIC → osteoblastic metastases on bone scan is virtually diagnostic of prostate cancer
23
Q

prostate cancer tx options

A

1. surgery (if clinically localized disease) : radical prostatectomy

2. radiation : ext beam or brachytx

3. hormonal

  • androgen deprivation tx
  • orchiectomy
  • LHRH analogs → suppress LH release
  • AR antagonists
24
Q

PSA

A

prostate specific antigen

  • pdt of normal and neoplastic prostate cells
    • pro-peptide, secreted in lumen → activated → degraded
  • fx: liquefaction of seminal coagulum
  • sm amounts of active and inactive PSA in serum
    • inactive PSA is free
    • active PSA is bound by protease inhibitors

in prostate cancer, absence of basal cells/ basement membrane allows “leakage” → larger fraction that beats processing, stays active

  • i.e. men with prostate cancer have more active (bound) and less inactive (free) PSA than men with BPH
25
Q

5alpha reductase deficiency

A